Nutex Health, Inc. (NUTX)

NASDAQ • Healthcare

$200.24

+$5.04 (+2.6%)

Market closed

Last close at September 11, 2026 at 20:00 UTC

Open$196

Day Range$195.59 - $202.5

Avg. Volume (3M)146.1K

Market Cap$1.3B

P/E Ratio7.6

52 Week Range

$83.99$204

Next EarningsIn 65 daysNov 17, 2026

Metrics Over Time

Where the Money Goes

Q2 2026

Revenueeverything earned$210.7M100%

Gross Profitminus cost of goods$141.2M67%

Operating Incomeminus R&D and overhead$121.7M58%

Net Incomeminus taxes and the rest$65.8M31%

In plain terms: out of every $100 in revenue, Nutex Health, Inc. keeps $31 as net profit.

Fundamentals & Financials

Revenue (TTM)

$846.7M

Net Income (TTM)

$179.9M

EPS (TTM)

$26.23

ROA (TTM)

18.65%

Current Ratio

Dividend Yield

1.13%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings

-105.8%Q4 2025-$2.95

+328.7%Q4 2025$7.76

-71.0%Q1 2026$1.61

+63.4%Q2 2026$6.52

+89.5%Q3 2026$9.38

Nov 17

in 65 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Nutex Health, Inc.

Nutex Health, Inc. (NASDAQ: NUTX) operates healthcare facilities and population-health services in the U.S. healthcare sector. The company, which works in medical care facilities and related provider support, generated $875.3 million of revenue in FY2025 and combines facility operations with provider-network and care-delivery support services.

Name

Nutex Health, Inc.

CEO

Thomas T. Vo

Website

www.nutexhealth.com

Industry

Healthcare

Employees

1,037

Today's Snapshot

AI-generated

NUTX closed 2.6% higher at 200.24, close to its 52-week high of 204.00. Nutex Health provided an update on its previously announced cybersecurity event.

Trading Volume

Below 10d avg (156.7K)

134.6K

vs S&P 500 Today

Outperforming Market

+1.65%

Updated: September 11, 2026 at 20:26 UTC

Technical Indicators

5 Buy2 Neutral1 Sell

NUTX shows a bullish technical posture with the price trading above its short, medium and long moving averages and the ADX around 31.7 confirming a meaningful trend. Momentum remains mixed: the CCI and momentum readings are positive while RSI and MACD are neutral, and the stock sits just above the upper Bollinger band which, together with an elevated ATR near 10.47, signals higher-than-normal volatility. OBV is not supporting the move, however, and the classic pivot sits below current price near 194.57 providing nearby technical support. Technical takeaway: overall strong buy with trend alignment but elevated volatility and overbought signals to monitor.

All signals